Aside from post-mastectomy repair, there is no medical need or rationale for cosmetic surgery. Cosmetic surgery patient deaths are unusual. When deaths occur as a result of cosmetic surgery, the media becomes enraged. It goes to reason that if you don’t need surgery, having it and dying as a result of it would be highly unacceptably and would garner a lot of media attention. California Center for Ketamine Therapy – Ketamine Clinic is one of the authority sites on this topic.
The most common type of anaesthesia used for cosmetic surgery is almost definitely general anaesthesia (GA). It is convenient, but it comes with risks that may be avoided. Cosmetic surgery has no preventable hazards because it is performed without a medical indication. Malignant hyperthermia (as seen in a recent Florida juvenile fatality), lack-of-oxygen errors resulting in brain damage or death, blood clots in the lungs, vomiting, and pulmonary edoema are all preventable concerns. These dangers arise as a result of the patient’s diminished ability to defend oneself because to the high level of trespass.
Fortunately, there is an alternate anaesthetic approach that produces minimum trespass and, as a result, maximises patient safety while removing the hazards associated with GA. Dr. Friedberg invented the BIS monitored propofol ketamine approach in 1997, which is now known as minimally invasive anaesthesia (MIA). The BIS monitor generates a value between 0 and 100 based on data obtained by a patient’s forehead sensor. The lower the number, the deeper the patient’s sleep.
Most patients don’t want to hear, feel, or remember their procedure, which is a common side effect of GA (BIS 45-60). MIA provides the same feeling as GA at BIS 60-75, but with 20-30% less medicine (i.e. propofol). Anesthesia for ‘Goldilocks’. By not allowing the BIS to go below 60 (‘too low’) or rise above 75 (‘too high’), it is possible to achieve this. With appropriate local analgesia, a BIS of 60-75 is “just right.”
Many anesthesiologists have accepted the idea of brain monitoring as a helpful tool in administering anaesthesia. Many anesthesiologists, however, have been hesitant to use technology that was approved by the FDA in 1996.
Given that the brain is being medicated, it stands to reason that administering anaesthetic medications to patients using a device like the BIS, which detects brain reaction, would be significantly more accurate. It’s rare that a member of the general public misses this simple point. Patients’ requests for this form of monitoring could be a motivator for change. To be safe, gradually providing propofol while following the BIS down to 75 allows patients to breathe on their own without needing supplemental oxygen. MIA has never had a lack-of-oxygen incident under these conditions.